Drugs / E7974
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00165802 | May 2006 → Dec 2007 | cancer | Eisai Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00130169 | Jan 2006 → Aug 2009 | cancer | Eisai Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00121732 | Jul 2005 → Oct 2009 | cancer | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E7974 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00121732 ↗ |
| Known as | ER-807974 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650465 ↗ |
| Route | Intravenous | “administered as an intravenous bolus dose” NCT00121732 ↗ |